These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12788656)

  • 1. Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates.
    Chakraborti S; Banerjea AC
    Mol Ther; 2003 Jun; 7(6):817-26. PubMed ID: 12788656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
    Unwalla H; Banerjea AC
    Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.
    Chakraborti S; Banerjea AC
    Biomacromolecules; 2003; 4(3):568-71. PubMed ID: 12741771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
    Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
    Unwalla H; Banerjea AC
    Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
    Sriram B; Banerjea AC
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F; Garcia J; Sigman D; Gaynor R
    Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
    Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription.
    Chepenik LG; Tretiakova AP; Krachmarov CP; Johnson EM; Khalili K
    Gene; 1998 Mar; 210(1):37-44. PubMed ID: 9524214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.
    Yamamoto R; Koseki S; Ohkawa J; Murakami K; Nishikawa S; Taira K; Kumar PK
    Nucleic Acids Res; 1997 Sep; 25(17):3445-50. PubMed ID: 9254702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.
    Kumar D; Chaudhury I; Kar P; Das RH
    J Gastroenterol Hepatol; 2009 May; 24(5):872-8. PubMed ID: 19220662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 VprB and C RNA cleavage by potent 10-23 DNAzymes that also cause reversal of G2 cell cycle arrest mediated by Vpr genes.
    Bano AS; Gupta N; Sharma Y; Sood V; Banerjea AC
    Oligonucleotides; 2007; 17(4):465-72. PubMed ID: 18078383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.
    Harrich D; Hooker CW; Parry E
    J Virol; 2000 Jun; 74(12):5639-46. PubMed ID: 10823871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
    Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
    Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.